Clinical Trial Update: A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma [Phase 1]

View source ↗

Summary

Phase I trial evaluating the effects of food and formulation on pharmacokinetics of KPT-330 (selinexor) in patients with sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• KPT-330

Snippet

Sponsor: Karyopharm Therapeutics Inc | Conditions: Sarcoma | Phase 1 | Status: COMPLETED | Results posted: 2024-01-08